Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v3-EN
Language English English
Date Updated 2019-04-03 2018-10-09
Drug Identification Number 02137984 02137984
Brand name TALWIN TALWIN
Common or Proper name Talwin 50mg Talwin 50mg
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients PENTAZOCINE PENTAZOCINE
Strength(s) 50MG 50MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N02AD N02AD
ATC description OPIOIDS OPIOIDS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-10-08 2018-10-08
Actual start date 2018-10-08
Estimated end date 2019-04-15 2018-12-07
Actual end date 2019-04-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. Delay in production
Health Canada comments